Kimberly Manhard
Director/Board Member at INHIBRX, INC.
Net worth: 66 294 $ as of 2024-03-30
Profile
Kimberly J.
Manhard currently works at Inhibrx, Inc., as Independent Director from 2020, Shoreline Biosciences, Inc., as Director from 2021, Toragen, Inc., as Director from 2020, ACADIA Pharmaceuticals, Inc., as Senior VP-Global Strategic Planning & Execution from 2024, and The Fleet Science Center, as Trustee.
Ms. Manhard also formerly worked at Ardea Biosciences, Inc., as Director & Corporate Compliance Officer from 2009 to 2016, Heron Therapeutics, Inc., as Executive VP-Drug Development in 2023, Bristol Myers Squibb Co., as Head-Regulatory Affairs, Eli Lilly & Co., as Principal, Exelixis, Inc., as Vice President-Regulatory Affairs from 2002 to 2003, Agouron Global Commercial Operations, as Head-Regulatory Affairs, and G.H.
Besselaar Associates, as Principal.
Ms. Manhard received her undergraduate degree from the University of Florida.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
HERON THERAPEUTICS INC
0.02% | 2023-04-17 | 23,933 ( 0.02% ) | 66 294 $ | 2024-03-30 |
Kimberly Manhard active positions
| Companies | Position | Start |
|---|---|---|
| INHIBRX, INC. | Director/Board Member | 2020-05-31 |
| ACADIA PHARMACEUTICALS INC. | Corporate Officer/Principal | 2024-01-29 |
| Fleet Science Center | Director/Board Member | - |
Shoreline Biosciences, Inc.
 Shoreline Biosciences, Inc. BiotechnologyHealth Technology Shoreline Biosciences, Inc. engages in biotechnology business activities. The company is headquartered in La Jolla, CA. | Director/Board Member | 2021-05-18 |
Toragen, Inc.
 Toragen, Inc. BiotechnologyHealth Technology Toragen, Inc. is a clinical-stage biotechnology company that is focused on developing treatments for HPV-induced cancers, starting with head and neck cancer. Toragen is based in San Diego, CA. The company is targeting the root cause of virally induced cancers. The company was founded by Andrew Sharabi and the CEO is Sandra I. Coufal. | Director/Board Member | 2020-04-30 |
Former positions of Kimberly Manhard
| Companies | Position | End |
|---|---|---|
| HERON THERAPEUTICS, INC. | Director/Board Member | 2023-02-20 |
Ardea Biosciences, Inc.
 Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | Chief Operating Officer | 2009-06-22 |
| EXELIXIS, INC. | General Counsel | 2002-12-31 |
| G.H. Besselaar Associates | Corporate Officer/Principal | - |
| ░░░ ░░░░░ ░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Training of Kimberly Manhard
| University of Florida | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 6 |
|---|---|
| HERON THERAPEUTICS, INC. | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| ELI LILLY AND COMPANY | Health Technology |
| EXELIXIS, INC. | Health Technology |
| ACADIA PHARMACEUTICALS INC. | Health Technology |
| INHIBRX, INC. | Health Technology |
| Private companies | 6 |
|---|---|
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | Health Technology |
| Agouron Global Commercial Operations | |
| G.H. Besselaar Associates | |
Shoreline Biosciences, Inc.
Shoreline Biosciences, Inc. BiotechnologyHealth Technology Shoreline Biosciences, Inc. engages in biotechnology business activities. The company is headquartered in La Jolla, CA. | Health Technology |
| Fleet Science Center | |
Toragen, Inc.
Toragen, Inc. BiotechnologyHealth Technology Toragen, Inc. is a clinical-stage biotechnology company that is focused on developing treatments for HPV-induced cancers, starting with head and neck cancer. Toragen is based in San Diego, CA. The company is targeting the root cause of virally induced cancers. The company was founded by Andrew Sharabi and the CEO is Sandra I. Coufal. | Health Technology |
- Stock Market
- Insiders
- Kimberly Manhard
